Who owns GENB?
Institutional ownership of Generate Biomedicines Inc. from Form 13F, Q2 2026
85 institutional managers reported holding Generate Biomedicines Inc. (GENB) in Form 13F filings for Q2 2026, with 37,372,632 shares worth $631M. The largest reported holder was FMR LLC. Managers that filed both quarters added a net 7,221,367 shares (+24.0%). 42 opened new positions and 13 sold out.
- Funds holding
- 85
- Value held
- $631M
- New / sold out
- 42 / 13
- Net shares, same filers
- +24.0%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of GENB
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| FMR LLC | $88.1M | 14.0% | 5,221,599 | Added |
| Capital World Investors | $71.1M | 11.3% | 4,215,632 | Added |
| Braidwell LP | $55.4M | 8.8% | 3,283,844 | Trimmed |
| Price T Rowe Associates Inc | $36.4M | 5.8% | 2,156,627 | Added |
| Norges Bank | $35.3M | 5.6% | 2,094,616 | New |
| ARCH Venture Management, LLC | $32.8M | 5.2% | 1,944,426 | Unchanged |
| HarbourVest Partners LLC | $29.1M | 4.6% | 1,722,210 | Unchanged |
| BlackRock, Inc. | $28.0M | 4.4% | 1,659,966 | New |
| Baker Bros. Advisors LP | $24.0M | 3.8% | 1,423,602 | Unchanged |
| JPMorgan Chase & Co | $23.8M | 3.8% | 1,409,649 | Trimmed |
| Deep Track Capital, LP | $22.5M | 3.6% | 1,333,815 | New |
| ARK Investment Management LLC | $21.7M | 3.4% | 1,284,617 | Added |
| Vanguard Capital Management LLC | $19.1M | 3.0% | 1,132,750 | Added |
| Harvard Management Co Inc | $18.7M | 3.0% | 1,111,100 | Unchanged |
| Nvidia Corp | $14.1M | 2.2% | 833,325 | Unchanged |
| Davern Capital Partners, LP | $13.9M | 2.2% | 824,679 | Added |
| Siren, L.L.C. | $12.4M | 2.0% | 736,104 | Unchanged |
| Geode Capital Management, LLC | $12.4M | 2.0% | 735,003 | Added |
| State Street Corp | $8.9M | 1.4% | 526,565 | New |
| Affinity Asset Advisors, LLC | $6.7M | 1.1% | 400,000 | Added |
| Morgan Stanley | $6.4M | 1.0% | 377,994 | Added |
| UBS Group AG | $5.5M | 0.9% | 326,273 | Trimmed |
| Sphera Funds Management LTD. | $4.1M | 0.7% | 245,000 | Added |
| Charles Schwab Investment Management Inc | $3.8M | 0.6% | 224,602 | New |
| Northern Trust Corp | $3.3M | 0.5% | 197,543 | New |
Share of 13F holdings is each fund's shares as a share of the 37,372,632 GENB shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Norges Bank New+$35.3M
- BlackRock, Inc. New+$28.0M
- Deep Track Capital, LP New+$22.5M
- FMR LLC Added+$16.9M
- Vanguard Capital Management LLC Added+$16.9M
- ARK Investment Management LLC Added+$13.3M
- Geode Capital Management, LLC Added+$10.4M
- State Street Corp New+$8.9M
- Davern Capital Partners, LP Added+$3.9M
- Charles Schwab Investment Management Inc New+$3.8M
Biggest sellers in Q2 2026
- JPMorgan Chase & Co Trimmed-$26.0M
- Alyeska Investment Group, L.P. Sold out-$6.3M
- Millennium Management LLC Trimmed-$6.0M
- Braidwell LP Trimmed-$5.2M
- ExodusPoint Capital Management, LP Sold out-$3.9M
- Goldman Sachs Group Inc Trimmed-$2.7M
- CenterBook Partners LP Trimmed-$2.3M
- Jane Street Group, LLC Sold out-$1.5M
- Silverarc Capital Management, LLC Sold out-$1.3M
- D. E. Shaw & Co., Inc. Sold out-$1.2M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $189M and sold $60.7M; 24 added and 10 trimmed.
Schedule 13D and 13G filings on GENB
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-11-05FMR LLC SCHEDULE 13G filed by Generate Biomedicines Inc.Schedule 13G
- 2026-05-15Flagship Pioneering, LLC SCHEDULE 13G filed by Generate Biomedicines Inc.Schedule 13G
- 2026-05-15Nally Michael SCHEDULE 13G filed by Generate Biomedicines Inc.Schedule 13G
Questions about GENB ownership
- Who owns GENB stock?
- 85 institutional investment managers reported GENB positions in their Form 13F filings for Q2 2026, holding 37,372,632 shares worth $631M in total. FMR LLC reported the largest position.
- Are funds buying or selling GENB?
- In Q2 2026, 42 managers opened new GENB positions, 24 added, 10 trimmed and 13 sold out. Managers that filed in both quarters added a net 7,221,367 shares.
- How current is this GENB institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to GENB by CUSIP. Options are left out. GENB news and filings · GENB insider trades · Top funds